US Stock MarketDetailed Quotes
PRCT PROCEPT BioRobotics
- 79.530
- +0.240+0.30%
Close Sep 27 16:00 ET
- 80.090
- +0.560+0.70%
Post 20:02 ET
4.13BMarket Cap-38606P/E (TTM)
80.610High78.520Low313.08KVolume79.670Open79.290Pre Close24.90MTurnover0.63%Turnover RatioLossP/E (Static)51.93MShares85.81052wk High16.40P/B3.94BFloat Cap24.83052wk Low--Dividend TTM49.58MShs Float85.810Historical High--Div YieldTTM2.64%Amplitude15.380Historical Low79.530Avg Price1Lot Size
PROCEPT BioRobotics Stock Forum
Sign in to post a comment
The market climbed after feeling the first day of pullback in nearly two weeks the day before.
Just after 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.42%, the $Dow Jones Industrial Average (.DJI.US)$ traded +0.14%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.57%.
Investors are digesting retail earnings and the tail end of tech reports, alongside comments made during the Democratic National Committee, where the Harris campaign made public t...
Just after 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.42%, the $Dow Jones Industrial Average (.DJI.US)$ traded +0.14%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.57%.
Investors are digesting retail earnings and the tail end of tech reports, alongside comments made during the Democratic National Committee, where the Harris campaign made public t...
38
20
Good morning, traders. Happy Wednesday. The market is advancing again after pulling back from a nearly ten day climb Tuesday. Retail earnings this morning came in mixed, the DNC is still roaring on in Chicago.
My name is Kevin Travers; here are stories moooving on the U.S. stock market today.
Target Corporation $Target (TGT.US)$ climbed 12% Wednesday after reporting Q2 results that exceeded expectations and boosted its ful...
My name is Kevin Travers; here are stories moooving on the U.S. stock market today.
Target Corporation $Target (TGT.US)$ climbed 12% Wednesday after reporting Q2 results that exceeded expectations and boosted its ful...
48
7
Recent insider selling of PROCEPT BioRobotics shares and lack of insider buying, along with not particularly high insider ownership, raises caution about the company. Consider the company's investment risks before purchasing.
PROCEPT BioRobotics has a conservative balance sheet and could probably eliminate its debt without much difficulty. Despite losing money over the last twelve months, the company's solid revenue growth may indicate a path to profitability.
Insider selling at PROCEPT BioRobotics' current share price levels doesn't imply major concern nor positivity. Lack of insider purchases in the past year and shares held by insiders, combined with past sales, call for careful investments due to potential company risks.
Upgrades
• $Allogene Therapeutics (ALLO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $9)
• $ChampionX (CHX.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $22 (from $25)
• $CSX Corp (CSX.US)$ : Stifel Upgrades to Buy from Hold - PT $37 (from $39)
• $TechnipFMC (FTI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $8 (from $9.50)
• $Norfolk Southern (NSC.US)$ : Stifel Upgrades to Buy from Hold - PT $2...
• $Allogene Therapeutics (ALLO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $9)
• $ChampionX (CHX.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $22 (from $25)
• $CSX Corp (CSX.US)$ : Stifel Upgrades to Buy from Hold - PT $37 (from $39)
• $TechnipFMC (FTI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $8 (from $9.50)
• $Norfolk Southern (NSC.US)$ : Stifel Upgrades to Buy from Hold - PT $2...
14
1
$PROCEPT BioRobotics (PRCT.US)$ 50 today?
2
Stocks on IPO and during their first year will face extreme volatility ![]()
. The stocks will requires many conditions, such as good management, good business plan and good luck, to ensure its survival. Investors, especially new ones, will need to pick them more carefully. ![]()
Here is the result for last week IPO stocks. Did you got the right ones?![]()
Here is the result for last week IPO stocks. Did you got the right ones?
8
IPOs see strong demand as investors are seeking new companies that offer innovative products and services in wide ranging and diverse areas. A number of well received IPOs have enjoyed terrific returns which could be attributed to market exuberance over these new listings. This comes as no surprise as the US market is the mainstay of most global portfolios of investors and also home to multiple fast growing companies across various industries. With the market reaching new all time highs, concerns are increasing about new listings overheating. The newly listed companies also tend to be more volatile during their first few earnings seasons as market expectations will rest on if they could deliver the promised targets. Investors need to be aware that early institutional investors look to exit their holdings within a year or so while retail investors are buying in, which results in increased volatility. Investment decisions should always be guided by a fundamental analysis of the company and its valuation to ensure that investors are not taking unnecessary risks to their portfolios by jumping on this IPO bandwagon blindly.
$Definitive Healthcare (DH.US)$
$DICE THERAPEUTICS, INC. (DICE.US)$
$Dutch Bros (BROS.US)$
$On Holding (ONON.US)$
$PROCEPT BioRobotics (PRCT.US)$
$Sportradar Group AG (SRAD.US)$
$Thoughtworks (TWKS.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Definitive Healthcare (DH.US)$
$DICE THERAPEUTICS, INC. (DICE.US)$
$Dutch Bros (BROS.US)$
$On Holding (ONON.US)$
$PROCEPT BioRobotics (PRCT.US)$
$Sportradar Group AG (SRAD.US)$
$Thoughtworks (TWKS.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
38
24
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Cypher : @Kevin Travers Check the last two paragraphs within the MACRO section, just before SECTORS. It’s quite redundant, could have condensed them into one paragraph.
Cypher : @Kevin Travers Check $PROCEPT BioRobotics (PRCT.US)$ section where they mention Joe Biden. Literally out of left field.
The lack editorial quality is truly outstanding
Kevin Travers Cypher : Thanks
Kevin Travers Cypher : Thanks, can you maybe help write this up tomorrow? We are short staffed this week
JacGoat23 : Powell just manipulating us and messing up with our freaking heads they not cutting rates it’s f shit
View more comments...